Strengthening Pharmaceutical Cold Chain Management in India

Recommendations Emerging from the 1st Cold Chain Community Meet (CC-CM)

Published by:
National Accreditation Body for Cold Chain Management (NAB-CCM)

Publication Date:
June 2026

Document Number:
NABCCM/WP/2026/JN1

Format: PDF

CLICK THE LINK BELOW TO DOWNLOAD THE WHITE PAPER

https://nab-ccm.com/wp-content/uploads/2026/07/White-Paper-CC-CM-June-2026.pdf

 

Executive Summary

Temperature-sensitive pharmaceutical products including vaccines, biologics, insulin, specialty drugs, blood products and other critical healthcare products require strict adherence to prescribed storage and transportation conditions throughout their lifecycle.

Despite significant progress in pharmaceutical distribution practices, gaps continue to exist in storage compliance, workforce competency, vendor qualification, hospital handling practices and monitoring of cold chain operations across the supply chain.

Recognizing these challenges, the 1st Cold Chain Community Meet (CC-CM) convened industry stakeholders to discuss opportunities for strengthening India’s pharmaceutical cold chain framework.
The discussions resulted in recommendations focused on:
• Regulatory improvements
• Manufacturer accountability
• Vendor qualification and certification
• Workforce training and competency development across all
stakeholders
• Hospital and retail compliance
• End-to-end audit and certification frameworks
• Strengthening Good Storage and Distribution Practices (GSDP)

This White Paper presents the collective recommendations emerging from the discussions and serves as a roadmap for future industry and regulatory action.